Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb 1;29(3):684.
doi: 10.1158/1078-0432.CCR-22-2968.

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter

Jonathan Q Trinh  1 , Moataz Ellithi  2 , Nicole Shonka  2 , Raymond C Bergan  2
Affiliations
Comment

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter

Jonathan Q Trinh et al. Clin Cancer Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The authors declare no potential conflicts of interest.

Comment in

Comment on

  • FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
    Fallah J, Brave MH, Weinstock C, Mehta GU, Bradford D, Gittleman H, Bloomquist EW, Charlab R, Hamed SS, Miller CP, Dorff SE, Chambers WA, Mixter BD, Dinin J, Pierce WF, Ricks TK, Tang S, Donoghue M, Pazdur R, Amiri-Kordestani L, Ibrahim A, Beaver JA. Fallah J, et al. Clin Cancer Res. 2022 Nov 14;28(22):4843-4848. doi: 10.1158/1078-0432.CCR-22-1054. Clin Cancer Res. 2022. PMID: 35727604 Free PMC article.

References

    1. Fallah J, Brave MH, Weinstock C, et al. FDA Approval Summary: Belzutifan for von Hippel-Lindau disease associated tumors. Clin Cancer Res. 2022. - PMC - PubMed
    1. Jonasch E, Donskov F, Iliopoulos O, et al. Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease. N Engl J Med. 2021;385(22):2036–2046. - PMC - PubMed
    1. Gläsker S, Van Velthoven V. Risk of hemorrhage in hemangioblastomas of the central nervous system. Neurosurgery. 2005;57(1):71–76; discussion 71–76. - PubMed

MeSH terms

Substances